International Stem Cell Corporation , a California-based biotechnology company developing novel stem cell based therapies and biomedical products, announced today that the company has been selected to give a platform presentation on its preclinical studies in Parkinson's at the 2015 American Academy of Neurology Annual Meeting in Washington, DC.
http://ift.tt/1GGFE63
http://ift.tt/1GGFE63
No comments:
Post a Comment